Impact of treatment timing and sequence of immune checkpoint inhibitors and anti-angiogenic agents for advanced non-small cell lung cancer: A systematic review and meta-analysis
2020 ◽
Vol 21
(2)
◽
pp. 106-113.e5
◽
2020 ◽